Publications by authors named "Alberto Fusi"

Claim this Profile
A
A randomised phase 2 study of intermittent versus continuous dosing of dabrafenib plus trametinib in patients with BRAF mutant advanced melanoma (INTERIM).
Alimu Dayimu, Avinash Gupta, Rubeta N Matin, Jenny Nobes, Ruth Board, Alberto Fusi

Eur J Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Life-threatening polymyositis with spontaneous hematoma induced by nivolumab in a patient with previously resected melanoma.
Wing K Liu, Nabeel Naban, Arvind Kaul, Nirav Patel, Alberto Fusi

Melanoma Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of carboplatin when administered after dacarbazine failure: Clinical benefit of sequential therapy.
Eve Merry, Maria Marples, Sarah Danson, David Harding, James Denny, Alberto Fusi

Mol Clin Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The successful treatment of metastatic androgen receptor-positive tumours of parotid origin with androgen receptor blockade and immunotherapy.
Angus G Dalgleish, Silvana Di Palma, Kannon Nathan, Barry Powell, Nirav Patel, Alberto Fusi

Eur J Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Apolipoprotein E and Other Inflammatory Markers Can Identify Non-Responding Patients to a Dendritic Cell Vaccine.
Hayley Leeman, Elwira Kaminska, Deborah Green, Mark Bodman-Smith, Andrew Gravett, Alberto Fusi

Transl Oncol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced effect of checkpoint inhibitors when given after or together with IMM-101: significant responses in four advanced melanoma patients with no additional major toxicity.
Angus G Dalgleish, Satvinder Mudan, Alberto Fusi

J Transl Med· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance for immunoregulation for long-term cancer control.
Alberto Fusi, Angus Dalgleish

Future Oncol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma.
Maria Romina Girotti, Filipa Lopes, Natasha Preece, Dan Niculescu-Duvaz, Alfonso Zambon, Alberto Fusi

Cancer Cell· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors.
Moritz Schütte, Thomas Risch, Nilofar Abdavi-Azar, Karsten Boehnke, Dirk Schumacher, Alberto Fusi

Nat Commun· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vasculogenic mimicry in small cell lung cancer.
Stuart C Williamson, Robert L Metcalf, Francesca Trapani, Sumitra Mohan, Jenny Antonello, Alberto Fusi

Nat Commun· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma.
Maria Romina Girotti, Gabriela Gremel, Rebecca Lee, Elena Galvani, Dominic Rothwell, Alberto Fusi

Cancer Discov· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 expression as a potential predictive biomarker.
Alberto Fusi, Lucia Festino, Gerado Botti, Giuseppe Masucci, Ignacio Melero

Lancet Oncol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dabrafenib and its use in the treatment of metastatic melanoma.
Samantha Bowyer, Rebecca Lee, Alberto Fusi, Paul Lorigan

Melanoma Manag· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal management of immune-related toxicities associated with checkpoint inhibitors in lung cancer.
Matthew Howell, Rebecca Lee, Samantha Bowyer, Alberto Fusi, Paul Lorigan

Lung Cancer· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PI3K/PTEN/AKT/mTOR polymorphisms: association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab-docetaxel.
Katharina Pfisterer, Alberto Fusi, Konrad Klinghammer, Maren Knödler, Anika Nonnenmacher

Head Neck· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression and activity of EGFR in human cutaneous melanoma cell lines and influence of vemurafenib on the EGFR pathway.
Alexander Gross, Annett Niemetz-Rahn, Anika Nonnenmacher, Johannes Tucholski, Ulrich Keilholz, Alberto Fusi

Target Oncol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanoma.
Maria Romina Girotti, Filipa Lopes, Natasha Preece, Dan Niculescu-Duvaz, Alfonso Zambon, Alberto Fusi

Cancer Cell· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of chemotherapy in the modern management of melanoma.
Rebecca Jane Lee, Noor Ul-Ain-Tariq, Alberto Fusi, Samantha Bowyer, Paul Lorigan

Melanoma Manag· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vemurafenib-induced nonautoimmune haemolytic anaemia.
Alberto Fusi, Jackie Hodgetts, Mike Dennis, Paul Lorigan

Melanoma Res· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer.
Radosław Polański, Cassandra L Hodgkinson, Alberto Fusi, Daisuke Nonaka, Lynsey Priest

Clin Cancer Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of circulating tumour cell detection in non-small-cell lung cancer.
Alberto Fusi, Robert Metcalf, Matthew Krebs, Caroline Dive, Fiona Blackhall

Curr Treat Options Oncol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of small spheres derived from various solid tumor cell lines: are they suitable targets for T cells?
Antonia Busse, Anne Letsch, Alberto Fusi, Anika Nonnenmacher, David Stather

Clin Exp Metastasis· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study).
Antonia Busse, Jérôme Rapion, Alberto Fusi, Stefan Suciu, Anika Nonnenmacher

Cancer Immunol Immunother· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biclonal non-small cell lung cancer in disseminated tumor cells and tissue.
Anna Puggina, Verena Kümmerlen, Korinna Jöhrens-Leder, Ulrich Keilholz, Alberto Fusi

J Thorac Oncol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of chemokine receptors on circulating tumor cells in patients with solid tumors.
Alberto Fusi, Zhian Liu, Verena Kümmerlen, Anika Nonnemacher, Judith Jeske

J Transl Med· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis